Bone marrow trephine track as incidental finding on CT scanning for anaemia and splenomegaly
Dural lymphoma mimicking subdural haematoma on computerized tomography
Managing the challenge of PTLD in liver and bowel transplant recipients
Haematopoietic and immune defects associated with GATA2 mutation
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia
Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B-CLL: implications for rituximab resistance in CLL
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood
Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react
Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload
Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol
Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia
CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms
Myeloid neoplasm with translocation t(2;11)(p21;q23–24), elevated microRNA 125b-1, and JAK2 exon 12 mutation
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network
DNA repair in diffuse large B-cell lymphoma: a molecular portrait
Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone?
No association between Annexin A5 genetic variants and deep venous thrombosis
Interactive Haematology Imagebank with Self Assessment